TORVANTA
Other · S&P 500 · data as of 2026-10-05

SUPN stock analysis: SUPN

SUPN (SUPN) is an S&P 500 company in Other. It grades weakest on momentum, growth and profitability.

The model's view of SUPN · subscribers

Where SUPN ranks among the 1,500 U.S. stocks the model scores each trading day, its expected return, the evidence for and against it, and whether the model portfolio holds it. The grades below describe the company's data; they are not the model's view.

See plans
What's happening with SUPN · updated 2026-10-05 · from prices and SEC filings

SUPN price performance

SUPN against the S&P 500, one year
-10%+0%+10%+20%S&P 500 +18%SUPN -10%2025-09-292026-10-05
Year to date-14.0%S&P 500 +14.5% · behind by 28.5 pts
1 year-11.6%S&P 500 +17.0% · behind by 28.6 pts
3 years+56.3%S&P 500 +89.3% · behind by 33.0 pts
5 years+59.9%S&P 500 +91.3% · behind by 31.4 pts

Total returns with dividends reinvested.

SUPN factor grades

Each grade compares SUPN with the rest of its sector (A+ best, F worst); the numbers behind it are shown with the typical figure for its peers.

–ValueFCF yield 0.8% (industry 6.0%)
C-GrowthRevenue growth +25% (industry +8%)EPS growth -267% (industry +10%)
D+ProfitabilityOperating margin -15.7% (industry 9.6%)ROIC -12.1% (industry 10.1%)
C-Momentum12-month change -12%From 52-wk high -25%

SUPN in plain numbers

SUPN key statistics

SectorOther
Industryn/a
IndexS&P 500
Market value$2.5B
Revenue growth (y/y)+25%
Free-cash-flow yield0.8%
Dividend yieldn/a
Next earnings (expected)2026-11-03
Valuation measures
Market value$2.5B
Enterprise value$2.3B
Price / sales3.0x
Price / book2.4x
EV / revenue2.8x
Financial highlights
Revenue, last 12 months$830.4M
Net income, last 12 months-$109.9M
EPS, last 12 months (GAAP)$-1.92
Gross margin88.1%
Operating margin-15.7%
Net margin-13.2%
Return on equity-10.5%
Return on invested capital-12.1%
Cash$180.0M
Free cash flow, last 12 months$18.8M
Current ratio2.08x

Company figures from its latest SEC filings; market value and returns from end-of-day prices.

SUPN earnings trends

Revenue vs earnings
-$58.4M$11.0M$80.3M$149.7M$219.1MSep 2024 Revenue: $175.7MDec 2024 Revenue: $174.2MMar 2025 Revenue: $149.8MJun 2025 Revenue: $165.5MSep 2025 Revenue: $192.1MDec 2025 Revenue: $211.6MMar 2026 Revenue: $207.7MJun 2026 Revenue: $219.1MSep 2024 Net income: $38.5MDec 2024 Net income: $15.3MMar 2025 Net income: -$11.8MJun 2025 Net income: $22.5MSep 2025 Net income: -$45.1MDec 2025 Net income: -$4.1MMar 2026 Net income: -$2.3MJun 2026 Net income: -$58.4MSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Net margin: 21.9%Net margin: 8.8%Net margin: -7.9%Net margin: 13.6%Net margin: -23.5%Net margin: -1.9%Net margin: -1.1%Net margin: -26.6%-27%-2%22%■ Revenue ■ Net income ━ Net margin
Earnings per share$-1.0$-0.6$-0.2$0.3$0.7Sep 2024 EPS (GAAP, diluted): $0.7Dec 2024 EPS (GAAP, diluted): $0.3Mar 2025 EPS (GAAP, diluted): $-0.2Jun 2025 EPS (GAAP, diluted): $0.4Sep 2025 EPS (GAAP, diluted): $-0.8Dec 2025 EPS (GAAP, diluted): $-0.1Mar 2026 EPS (GAAP, diluted): $-0.0Jun 2026 EPS (GAAP, diluted): $-1.0Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026■ EPS (GAAP, diluted) Change from a year earlier: Sep 2025 -216% · Dec 2025 -126% · Jun 2026 -352%

From the company's 10-Q and 10-K filings with the SEC.

SUPN financials (from SEC filings)

Fiscal yearFY2021FY2022FY2023FY2024FY2025
Revenue$579.8M$667.2M$607.5M$661.8M$719.0M
Net income$53.4M$60.7M$1.3M$73.9M-$38.5M
EPS (GAAP)$0.98$1.02$-0.00$1.32$-0.68
Free cash flown/a$115.2M$110.5M$171.2M$46.0M

SUPN earnings history

ReportedEPS (GAAP)EPS y/yRevenue y/yStock vs S&P 500, 2 days
2026-08-03$-1.01-352%+32%-6.3%
2026-07-22$-1.01-352%+32%-0.1%
2026-05-05$-0.04n/a+39%+3.6%
2026-04-22$-0.04n/a+39%+2.0%
2026-02-24$-0.07-126%+21%+9.5%
2026-02-12$-0.07-126%+21%+0.5%

About SUPN

HeadquartersRockville, MD
Industry (SEC code)Pharmaceutical Preparations
Fiscal year endsDecember 31
Incorporated inDE
Listed onNasdaq
FormerlySUPERNUS PHARMACEUTICALS INC

From the company's SEC registration record.

Companies similar to SUPN

CompanyMarket valueP/ERevenue growthOperating margin12-month change
SUPN SUPN$2.5Bn/a+25%-15.7%-12%
LQDA LQDA$2.5B19.9xn/a37.4%+23%compare
SDGR SDGR$2.5Bn/a+9%-59.2%+58%compare
KMT KMT$2.5B7.4x+20%20.1%+54%compare
LPG LPG$2.5B7.6x+81%57.6%+120%
WLY WLY$2.5B13.1x-0%14.9%+26%
CENT CENT$2.5B14.7x-1%8.1%+24%

All Other stock ratings

Frequently asked questions

Is SUPN stock a buy?

Torvanta does not tell individuals what to buy. Its grades for SUPN are shown above. Subscribers see the model's rank, expected return and whether the model portfolio holds it. This is research, not a recommendation.

When does SUPN report earnings next?

Based on its filing history, Torvanta expects SUPN to report around 2026-11-03.

How has SUPN performed against the S&P 500?

Over the past year SUPN returned -11.6%, against +17.0% for the S&P 500, dividends reinvested.

See the model's view

Subscribers get the model's rank and expected return for every covered company, the reasoning behind each, and the Torvanta model portfolio's trades each trading day, sized and explained, at three risk levels.

See plans Or get the free weekly newsletter

Torvanta is research only - not investment advice and not a recommendation to buy or sell any security. Grades describe a company's reported data against its sector; they are not the model's view, change as data changes and can be wrong. Financial figures come from the company's SEC filings; returns include reinvested dividends. Past performance does not predict future results.

All stock ratings · Stock lists · AI stock research · Model portfolio · Research · Disclaimer